Known targets — ChEMBL curated mechanism
ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIN2B | Q13224 | 4/20 | 0.48 |
| ▸ | GRIN1 | Q05586 | 2/20 | 0.45 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.44 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.44 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.44 |
| ▸ | CXCR4 | P61073 | 6/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | DRD2 | P14416 | 2/20 | 0.40 |
| ▸ | DRD3 | P35462 | 1/20 | 0.40 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1883122 | 0.99 | GRIN2B (0.49) | GRIN2BGRIN1HDAC1HDAC8HDAC6 | |
| SCHEMBL29823333 | 0.99 | GRIN2B (0.49) | GRIN2BGRIN1HDAC1HDAC8HDAC6 | |
| SCHEMBL8783707 | 0.84 | GRIN2B (0.67) | GRIN2BGRIN1HDAC1HDAC8HDAC6 | |
| SCHEMBL29823562 | 0.82 | DRD2 (0.56) | GRIN2BHDAC1HDAC8HDAC6CXCR4 | |
| SCHEMBL29823341 | 0.82 | GRIN2B (0.45) | GRIN2BCXCR4CYP3A4CYP2D6L3MBTL1 | |
| SCHEMBL1877403 | 0.82 | DRD2 (0.56) | GRIN2BHDAC1HDAC8HDAC6CXCR4 | |
| SCHEMBL1876490 | 0.82 | GRIN2B (0.45) | GRIN2BCXCR4CYP3A4CYP2D6L3MBTL1 | |
| SCHEMBL14207345 | 0.81 | GRIN2B (0.51) | GRIN2BGRIN1HDAC1HDAC8HDAC6 | |
| SCHEMBL14207337 | 0.81 | GRIN2B (0.51) | GRIN2BGRIN1HDAC1HDAC8HDAC6 | |
| Bromide SCHEMBL4550690 | 0.80 | HDAC1 (0.52) | GRIN2BHDAC1HDAC6CXCR4CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7629337-B2 | Chemokine receptor binding heterocyclic compounds | GENZYME CORPORATION (US) | 2009-12-08 | — | — | US | disclosed |
| US-20060264434-A1 | Chemokine receptor binding heterocyclic compounds | ANORMED INC. (CA) | 2006-11-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060264434-A1 | Chemokine receptor binding heterocyclic compounds | CCR5, CXCR4, CXCR1 | GRIN2B 1115/4885GRIN1 777/4885HDAC1 950/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.